The Patients Before Monopolies Act, introduced in both the House and Senate, gives parent companies of PBMs three years to divest from pharmacies or face penalties. 

Bottles of duloxetine manufactured by Rising Pharmaceuticals are being recalled due to higher-than-normal levels of nitrosamine contaminants. The recall is classified as Class II, the second most serious type.

A line of syringes manufactured by Cardinal Health may fail to properly inject insulin when used with needleless IV connectors. 

The IV bags caused multiple patients to experience severe cardiac distress. The judge who sentenced former doctor Raynaldo Rivera Ortiz Jr. said his actions were “tantamount to attempted murder."

Specific FHC-branded insertion tubes used in brain surgery are 20mm longer than expected and could pose a serious risk to patients. 

There have been no reported injuries. However, due to the risk of death or paralysis associated with metal debris entering brain tissue, the recall is designated Class I, the most serious of its type. 

All serial numbers and lots of several Philips ventilators are at risk for damaged airflow sensors if used with in-line nebulizers.

Rechargeable batteries used on CADD-Solis Li-ion infusion systems may short out if damaged, possibly causing the case to melt. No injuries have been reported.